MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

20 Oct 2023 Evaluate
A fair growth of 16.90% in the revenue at Rs. 5953.63 millions was reported in the September 2023 quarter as compared to Rs. 5092.99 millions during year-ago period.Net profit stood at Rs. 1187.37  millions  compared to Rs. 1068.78 millions in the corresponding previous quarter,high by 11.10%.The company reported a good operating profit of 1724.53 millions compared to 1536.59 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 5953.63 5092.99 16.90 11738.13 9991.69 17.48 21612.20 21232.14 1.79
Other Income 53.69 100.20 -46.42 72.20 195.13 -63.00 289.57 147.04 96.93
PBIDT 1724.53 1536.59 12.23 3674.65 3099.20 18.57 6712.50 6307.64 6.42
Interest 3.99 1.33 200.00 7.95 2.68 196.64 5.47 279.62 -98.04
PBDT 1720.54 1535.26 12.07 3666.70 3096.52 18.41 6707.03 6028.02 11.26
Depreciation 131.29 99.35 32.15 257.41 198.14 29.91 420.94 378.77 11.13
PBT 1589.25 1435.91 10.68 3409.29 2898.38 17.63 6286.09 5649.25 11.27
TAX 401.88 367.13 9.47 867.42 742.27 16.86 1616.48 1462.01 10.57
Deferred Tax 14.88 28.20 -47.23 44.43 41.05 8.23 110.37 85.74 28.73
PAT 1187.37 1068.78 11.10 2541.87 2156.11 17.89 4669.61 4187.24 11.52
Equity 245.05 245.05 0.00 245.05 245.05 0.00 245.05 245.05 0.00
PBIDTM(%) 28.97 30.17 -3.99 31.31 31.02 0.93 31.06 29.71 4.55
Peers
Company Name CMP
Sun Pharma. Inds. 1842.10
Dr. Reddys Labs. 1225.00
Cipla 1389.85
Lupin 2069.50
Zydus Lifesciences 1216.50
View more..